|
Instil Bio, Inc. (TIL) DCF Valoración
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Instil Bio, Inc. (TIL) Bundle
¿Busca determinar el valor intrínseco de Incushil Bio, Inc.? Nuestra (TIL) DCF Calculator integra datos del mundo real con características integrales de personalización, lo que le permite refinar sus pronósticos y mejorar sus opciones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -6.5 | -33.4 | -154.0 | -217.4 | -146.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -24194.2 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .0 | .3 | 2.8 | 6.0 | 4.8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 185.51 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -6.5 | -33.6 | -156.8 | -223.4 | -150.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -24379.71 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | 8.9 | 241.7 | 454.1 | 260.9 | 150.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 3.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 2299.28 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | 1.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 855.8 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 1.0 | 3.5 | 5.6 | 2.4 | 1.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 2532.61 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.8 | -50.8 | -57.8 | -84.6 | -20.7 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | -36823.19 | 100 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -6.5 | -33.8 | -156.8 | -221.3 | -150.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -6.2 | -86.2 | -205.4 | -303.1 | -167.9 | -1.2 | .0 | .0 | .0 | .0 |
| WACC, % | 10 | 10.03 | 10.03 | 10.01 | 10.03 | 10.02 | 10.02 | 10.02 | 10.02 | 10.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 77 | |||||||||
| Equity Value | -78 | |||||||||
| Diluted Shares Outstanding, MM | 7 | |||||||||
| Equity Value Per Share | -11.99 |
What You Will Get
- Pre-Filled Financial Model: Instil Bio, Inc.'s (TIL) actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
- Instant Calculations: Automatic updates ensure you see results as you make changes.
- Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.
Key Features
- Real-Life TIL Data: Pre-filled with Instil Bio, Inc.'s historical financials and future forecasts.
- Fully Customizable Inputs: Modify revenue growth, profit margins, discount rates, tax implications, and capital investments.
- Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation results.
- User-Friendly Design: Intuitive, organized, and suitable for both professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Instil Bio data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Instil Bio’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Instil Bio, Inc. (TIL)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Accurate Data: Instil Bio’s historical and projected financials are preloaded for precise calculations.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Should Use Instil Bio, Inc. (TIL)?
- Investors: Gain insights and make informed decisions with our advanced therapeutic solutions.
- Healthcare Professionals: Utilize our innovative treatments to enhance patient care and outcomes.
- Researchers: Access cutting-edge research tools to advance your studies in cell therapy.
- Pharmaceutical Companies: Collaborate with us to explore new opportunities in the biotech field.
- Educators and Students: Leverage our resources to enrich learning in biotechnology and pharmacology courses.
What the Template Contains
- Historical Data: Includes Instil Bio, Inc.'s (TIL) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Instil Bio, Inc.'s (TIL) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Instil Bio, Inc.'s (TIL) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.